neuroimmunology.wordpress.com
NeuroImmunology | Updating on disimmune neurological disordersUpdating on disimmune neurological disorders
http://neuroimmunology.wordpress.com/
Updating on disimmune neurological disorders
http://neuroimmunology.wordpress.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
0.7 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
5
SSL
EXTERNAL LINKS
1
SITE IP
192.0.78.13
LOAD TIME
0.672 sec
SCORE
6.2
NeuroImmunology | Updating on disimmune neurological disorders | neuroimmunology.wordpress.com Reviews
https://neuroimmunology.wordpress.com
Updating on disimmune neurological disorders
neuroimmunology.wordpress.com
Fingolimod, two years view | NeuroImmunology
https://neuroimmunology.wordpress.com/2011/06/02/fingolimod-two-years-view
Updating on disimmune neurological disorders. Fingolimod, two years view. The last issue of the Lancet Neurology. Journal, has published the extension phase study of the TRANSFORMS trial. Briefly, the TRANSFORMS trial was a randomized controlled trial comparing i.m. interferon beta 1a versus two different doses of fingolimod (0.5mg and 1.25mg). Its results were published on New England Journal of Medicine. 2 June, 2011. Laquo; The shameful story of Rituximab in Multiple Sclerosis. Do you want to comment?
KIR4.1 antibodies: A revolution in multiple sclerosis | NeuroImmunology
https://neuroimmunology.wordpress.com/2012/07/16/kir4-1-antibodies-a-revolution-in-multiple-sclerosis
Updating on disimmune neurological disorders. KIR41 antibodies: A revolution in multiple sclerosis. This week we had the opportunity to read a paper in the New England Journal of Medicine, describing, in my opinion, a breakthrough finding in MS. It’s published by Srivastava and coworkers, from the University of Munich. It describes the presence of antibodies against the KIR4.1 potassium channel in almost 50% of MS patients. Being, in my opinion, much less important from the patient care point of view.
Pills for multiple sclerosis | NeuroImmunology
https://neuroimmunology.wordpress.com/2012/06/24/pills-for-multiple-sclerosis
Updating on disimmune neurological disorders. Pills for multiple sclerosis. At this moment there is only one treatment fully available in Europe, fingolimod. Gilenya), four more laquinimod. Have completed phase III trials and another one, firategrast. Is still on phase II trials but shows promising results. So, let’s start:. Fingolimod is currently available in the US and Europe. We’ve wrote about it before. Annualized relapse rate showed a 50% reduction in comparison to placebo. Of the drug. Other s...
The shameful story of Rituximab in Multiple Sclerosis | NeuroImmunology
https://neuroimmunology.wordpress.com/2011/03/27/the-shameful-story-of-rituximab-in-multiple-sclerosis
Updating on disimmune neurological disorders. The shameful story of Rituximab in Multiple Sclerosis. Two weeks ago a few collegues from Spain and I attended the 3rd Preceptorship Program in MS at Steven Hauser’s department in UCSF. The scientific program and the overall quality of the course were outstanding. We had the opportunity to hear and ask those that have been ahead of MS research in the last years ( Oksenberg. And, of course, Hauser. The one about Rituximab. And started the whole process again&#...
Fingolimod unexpected death | NeuroImmunology
https://neuroimmunology.wordpress.com/2011/12/25/fingolimod-unexpected-death
Updating on disimmune neurological disorders. A few days ago we had access to this alert in Medscape. An MS patient, that had completed the 6-hour vigilance period after the first dose of fingolimod, died unexpectedly the next day. We don’t know much about it and we should wait until this case is resolved and an official report released. We only know that the patient was already taking beta-blockers and calcium channel antagonists. 25 December, 2011. Laquo; Rituximab vs Ocrelizumab in multiple sclerosis.
TOTAL PAGES IN THIS WEBSITE
5
neuroimmunology.info - This domain may be for sale!
Find the best information and most relevant links on all topics related to neuroimmunology.info. This domain may be for sale!
日本神経免疫学会
日本神経免疫学会 事務局 589-0014 大阪府大阪狭山市大野東３７７ ２ 近畿大学医学部神経内科学教室内. Tel 072-366-0221 Fax 072-368-4846 E-mail: jsni@neuro.med.kyushu-u.ac.jp. The Japanese Society for Neuroimmunology.
neuroimmunology.net - This website is for sale! - neuroimmunology Resources and Information.
The owner of neuroimmunology.net. Is offering it for sale for an asking price of 1295 USD! This webpage was generated by the domain owner using Sedo Domain Parking. Disclaimer: Sedo maintains no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo nor does it constitute or imply its association, endorsement or recommendation.
NEUROIMMUNOLOGY – updating on neuroimmunological diseases
Updating on neuroimmunological diseases. Paper Club week of December 30, 2016. December 30, 2016. Paper Club B-Cell Depletion – A Frontier in Monoclonal Antibodies for Multiple Sclerosis. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis. Digest powered by RSS Digest. Paper Club week of November 4, 2016. November 4, 2016. Paper Club week of July 29, 2016. July 29, 2016. Paper Club week of June 17, 2016. June 17, 2016.
UZH - Neuroimmunology - Neuro- and Tumorimmunology
We have a new homepage, please visit us at the Institute of Experimental Immunology. Http:/ www.immunology.uzh.ch. May 21, 2015.
NeuroImmunology | Updating on disimmune neurological disorders
Updating on disimmune neurological disorders. Moving to NeuroImmunology Club. It’s been a while since i worte the last post here. Many subjects should have been discussed and others updated but several things, one of them being the Twitter time sink, prevented more frequent updates on the blog. Two additional features have been added to the blog:. This site will still be available but won’t be updated anymore so, if you want to keep updated in NeuroImmunology, please change your feed to http:/ neur...
Neuroimmunology Australia
Welcome to the Neuroimmunology Australia website. Neuroimmunology Australia was formed in 2011, and is a collective of neurologists, basic immunologists and. Clinical immunologists with an interest in immune-mediated diseases of the central nervous system, the. Peripheral nerves, the neuromuscular junction, the autonomic nervous system and skeletal muscle. The aims of the group are:. To provide a forum for scientific discussion of these topics. To hold workshops from time to time on these topic.
Home | Neuroimmunology Program
How to help us? Diagnosis, treatment and research on inflammatory diseases of the brain. Better Diagnosis can lead to a better personal treatment. You can benefit from an early diagnosis. Artículo de revisión en @NEJM. Mediadas por anticuerpos by #josepdalmau. Antibody-Mediated Encephalitis NEJM https:/ t.co/vMIkEnoQWa. Follow us on Twitter. XXII Award 2018 Claustre de Doctors de la Universitat de Barcelona. The Cloister of Doctors of the Universitat de Barcelona. Wednesday, 8 March 2017. This week one o...
Neuroimmunopharmacology
Neuroimmunopharmacology
Unification of 3 research domains. Acknowledges and embraces the bi-directional relationship between the immune system and the brain. Immune to brain communication. Brain to immune communication. Examine the interplay between neuronal and non-neuronal cells of the central nervous system. Peripheral immune cells in the brain.
SOCIAL ENGAGEMENT